Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Trusted Resources

  • Education
  • Videos & Visuals
  1. Home
  2. Trusted Resources
cmaj
Jan 29, 2024
Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome
Read more
ScienceDirect
Jan 28, 2024
Hereditary transthyretin amyloidosis with hydrocephalus at 27 years old: A case report
Read more
National Library of Medicine
Jan 25, 2024
Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study
Read more
National Library of Medicine
Jan 22, 2024
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment
Read more
Springer Link
Jan 18, 2024
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is an underrecognized cause of heart failure due to misfolded wild-type transthyretin (TTRwt) myocardial…
Read more
Springer Link
Jan 03, 2024
Development and Testing of a Chronic-Disease Patient Experience Mapping Toolbox
BackgroundStakeholders increasingly expect research and care delivery to be guided by and to optimize patient experiences. However, standardized tools to engage…
Read more
Tafamidis Efficacy
Jan 02, 2024
Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study
Read more
National Library of Medicine
Dec 24, 2023
Light-Chain Amyloidosis: The Great Impostor
Read more
WILEY Online Library
Dec 14, 2023
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment
Read more
Transthyretin cardiac amyloidosis and mechanisms of drug action.
Nov 30, 2023
Recent Progress in the Development and Clinical Application of New Drugs for Transthyretin Cardiac Amyloidosis
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on